RxDoctor Payments Data

Kathleen Kearney

Critical Care Medicine · New York, NYNPI 1881987345

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $9,000 of the $13,714 with a category attached, or 65.6%. Abiomed accounts for 73.1% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $11,115 and has fallen 97.2% since, to $308 in 2025. Among critical care medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,714in general payments, 2019–2025

Across 92 payments — averaging $149.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$10K
  • E.r. Squibb & Sons, L.L.C.$626
  • Boston Scientific$509
  • Johnson & Johnson$455
  • Shockwave Medical, Inc$378
  • Pfizer$325
  • plus $1K from 13 others

What the payments were for

  • Speaking & faculty fees$9,00066%
  • Travel & lodging$1,0257%
  • Food & beverage$3,68027%
  • Education$90%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,714 in reported general payments places this provider in the 95th percentile of 442 critical care medicine providers in New York.

See all critical care medicine providers in New York

Other critical care medicine in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →